Losartan: lessons learned from the RENAAL study

Author： Shahinfar Shahnaz   Lyle Paulette A   Zhang Zhongxin   Keane William F   Brenner Barry M  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.7, Iss.5, 2006-04, pp. : 623-630

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recruiting Gay Alcohol Establishments for Studies: Lessons Learned From the SILAS Study

By Jones-Webb Rhonda   Kilian Gunna   Cain-Nielsen Anne   Rosser B. R. Simon   Brady Sonya  

Substance Use & Misuse, Vol. 48, Iss. 3, 2013-02 ,pp. : 194-199

Informa Healthcare

Access to resources Recommend Favorite

Losartan: real benefits in RENAAL disease for patients with type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1290, 2001-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite

Lessons learned from development of docetaxel

By Strother Robert Matthew   Sweeney Christopher  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 7, 2008-07 ,pp. : 1007-1019

Informa Healthcare

Access to resources Recommend Favorite

Lessons Learned from the Irinotecan Metabolic Pathway

By  

Current Medicinal Chemistry, Vol. 10, Iss. 1, 2003-01 ,pp. : 41-49

Bentham Science Publishers

Access to resources Recommend Favorite

Recruitment and Retention of Adolescents in a Smoking Trajectory Study: Who Participates and Lessons Learned

By Diviak Kathleen   Wahl Sarah   O'keefe John   Mermelstein Robin   Flay Brian  

Substance Use & Misuse, Vol. 41, Iss. 2, 2006-02 ,pp. : 175-182

Informa Healthcare

Access to resources Recommend Favorite